{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T10:32:54Z","timestamp":1761647574078},"reference-count":37,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2008,11,1]],"date-time":"2008-11-01T00:00:00Z","timestamp":1225497600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Revue Neurologique"],"published-print":{"date-parts":[[2008,11]]},"DOI":"10.1016\/j.neurol.2008.02.036","type":"journal-article","created":{"date-parts":[[2008,4,21]],"date-time":"2008-04-21T16:11:59Z","timestamp":1208794319000},"page":"902-911","source":"Crossref","is-referenced-by-count":4,"title":["Manifestations oculaires des maladies du muscle et de la jonction neuromusculaire"],"prefix":"10.1016","volume":"164","author":[{"given":"I.","family":"P\u00e9nisson-Besnier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Lamirel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.neurol.2008.02.036_bib1","series-title":"Pathologie orbito-palp\u00e9brale. Rapport de la soci\u00e9t\u00e9 fran\u00e7aise d\u2019ophtalmologie","article-title":"Orbitopathie dysthyro\u00efdienne","author":"Adenis","year":"1998"},{"key":"10.1016\/j.neurol.2008.02.036_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0035-3787(04)70887-5","article-title":"Syndromes myasth\u00e9niques cong\u00e9nitaux\u00a0: expression ph\u00e9notypique et caract\u00e9risation physiopathologique","volume":"160","author":"Andreux","year":"2004","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2008.02.036_bib3","first-page":"307","article-title":"Myosite orbitaire\u00a0: \u00e9tude clinique, radiologique et profil \u00e9volutif","volume":"159","author":"Attarian","year":"2003","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2008.02.036_bib4","first-page":"209","article-title":"Myopathie proximale avec myotonie (PROMM)\u00a0: \u00e9tude clinique et histologique","volume":"157","author":"Bassez","year":"2001","journal-title":"Rev Neurol.(Paris)"},{"key":"10.1016\/j.neurol.2008.02.036_bib5","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.nmd.2006.05.006","article-title":"A systematic review of diagnostic studies in myasthenia gravis","volume":"16","author":"Benatar","year":"2006","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.neurol.2008.02.036_bib6","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005081.pub2","article-title":"Medical and surgical treatment for ocular myasthenia","volume":"19","author":"Benatar","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.neurol.2008.02.036_bib7","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S0035-3787(06)75020-2","article-title":"Errance diagnostique dans les myopathies mitochondriales\u00a0: \u00e9tude de 12 patients thymectomis\u00e9s","volume":"162","author":"Ben Yaou","year":"2006","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2008.02.036_bib8","first-page":"13","article-title":"Orbital radiation for Graves ophthalmopathy. A report by the American academy of ophthalmology","author":"Bradley","year":"2007","journal-title":"Ophthalmology"},{"key":"10.1016\/j.neurol.2008.02.036_bib9","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1038\/ng0298-164","article-title":"Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy","volume":"18","author":"Brais","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2008.02.036_bib10","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1055\/s-2008-1040826","article-title":"Oculopharyngeal muscular dystrophy","volume":"19","author":"Brais","year":"1999","journal-title":"Semin Neurol"},{"key":"10.1016\/j.neurol.2008.02.036_bib11","doi-asserted-by":"crossref","first-page":"2843","DOI":"10.1172\/JCI29894","article-title":"Myasthenia gravis: past, present, and future","volume":"116","author":"Conti-Fine","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/j.neurol.2008.02.036_bib12","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1212\/01.WNL.0000054481.84978.F9","article-title":"Myotonic dystrophy type 2: molecular, diagnostic and clinical spectrum","volume":"60","author":"Day","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.02.036_bib13","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0755-4982(05)83944-2","article-title":"Botulisme\u00a0: un diagnostic clinique","volume":"34","author":"Delbos","year":"2005","journal-title":"Presse Med"},{"key":"10.1016\/j.neurol.2008.02.036_bib14","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0002-9394(14)77885-7","article-title":"Long-term follow-up of facioscapulohumeral muscular dystrophy and Coats\u2019 disease","volume":"110","author":"Desai","year":"1990","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/j.neurol.2008.02.036_bib15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.nmd.2004.12.008","article-title":"Mitochondrial encephalomyopathies: an update","volume":"15","author":"DiMauro","year":"2005","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.neurol.2008.02.036_bib16","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0960-8966(00)00173-5","article-title":"Therapeutic options in ocular myasthenia gravis","volume":"11","author":"Evoli","year":"2001","journal-title":"Neuromuscul Disord"},{"key":"10.1016\/j.neurol.2008.02.036_bib17","series-title":"Neuro-ophtalmologie","first-page":"284","article-title":"Pathologie orbitaire","author":"Fardeau","year":"2002"},{"key":"10.1016\/j.neurol.2008.02.036_bib18","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/brain\/110.3.631","article-title":"Retinal vascular abnormalities in facioscapulohumeral muscular dystrophy. A general association with genetic and therapeutic implications","volume":"110","author":"Fitzsimons","year":"1987","journal-title":"Brain"},{"key":"10.1016\/j.neurol.2008.02.036_bib19","doi-asserted-by":"crossref","DOI":"10.1016\/S0035-3787(04)71003-6","article-title":"Maladies musculaires g\u00e9n\u00e9tiques caus\u00e9es par une excitabilit\u00e9 anormale de la membrane","volume":"160","author":"Fontaine","year":"2004","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2008.02.036_bib20","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/S0035-3787(05)85237-3","article-title":"S\u00e9miologie \u00e9lectrophysiologique des canalopathies musculaires suivant les mutations causales","volume":"161","author":"Fournier","year":"2005","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/j.neurol.2008.02.036_bib21","series-title":"Myotonic dystrophy: present management, future therapy","year":"2004"},{"key":"10.1016\/j.neurol.2008.02.036_bib22","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/85520","article-title":"Auto-antibodies to the receptor tyrosine kinase MuSK in patients with myasthenia gravis without acetylcholine receptor antibodies","volume":"7","author":"Hoch","year":"2001","journal-title":"Nat Med"},{"key":"10.1016\/j.neurol.2008.02.036_bib23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1212\/WNL.45.3.516","article-title":"The gamma-subunit of the acetylcholine receptor is not expressed in the levator palpebrae superioris","volume":"45","author":"Kaminski","year":"1995","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.02.036_bib24","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1126\/science.1062125","article-title":"Myotonic dystrophy type 2 caused by aCCTGexpansion in intron 1 of ZNF9","volume":"293","author":"Liquori","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.neurol.2008.02.036_bib25","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1002\/ana.410410404","article-title":"Acetylcholine receptor expression in human extraocular muscles and their susceptibility to myasthenia gravis","volume":"41","author":"MacLennan","year":"1997","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2008.02.036_bib26","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/82638","article-title":"Perlecan, the major proteoglycan of basement membranes, is altered in Schwartz-Jampel syndrome (chondrodystrophic myotonia)","volume":"26","author":"Nicole","year":"2000","journal-title":"Nat. Genet."},{"key":"10.1016\/j.neurol.2008.02.036_bib27","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1002\/mus.880181314","article-title":"On the significance of retinal vascular disease and hearing loss in facioscapulohumeral muscular dystrophy","volume":"2","author":"Padberg","year":"1995","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.neurol.2008.02.036_bib28","unstructured":"P\u00e9nisson-Besnier I (2005). Dystrophie myotonique de type 2. Trait\u00e9 de neurologie, Encycl Med Chir (Elsevier, Paris), 17-100-15, p. 6."},{"key":"10.1016\/j.neurol.2008.02.036_bib29","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1212\/WNL.46.1.30","article-title":"Muscles of a different \u201ccolor\u201d: the unusual properties of the extraocular muscles may predispose or protect them in neurogenic and myogenic disease","volume":"46","author":"Porter","year":"1996","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.02.036_bib30","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/ana.410350305","article-title":"Myotonic dystrophy with no trinucleotide repeat expansion","volume":"35","author":"Thornton","year":"1994","journal-title":"Ann Neurol"},{"key":"10.1016\/j.neurol.2008.02.036_bib31","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/570","article-title":"Genetic mapping of a second myotonic dystrophy locus","volume":"19","author":"Ranum","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/j.neurol.2008.02.036_bib32","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1212\/WNL.44.8.1448","article-title":"Proximal myotonic myopathy: a new dominant disorder with myotonia, muscle weakness, and cataracts","volume":"44","author":"Ricker","year":"1994","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.02.036_bib33","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1086\/444507","article-title":"Botulism","volume":"41","author":"Sobel","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.neurol.2008.02.036_bib34","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1136\/bjo.2007.124156","article-title":"Idiopathic orbital inflammatory syndrome: clinical features and treatment outcomes","volume":"91","author":"Swamy","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/j.neurol.2008.02.036_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/BF00692226","article-title":"Nuclear inclusions in oculopharyngeal dystrophy","volume":"49","author":"Tom\u00e9","year":"1980","journal-title":"Acta Neuropathol"},{"key":"10.1016\/j.neurol.2008.02.036_bib36","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1212\/01.WNL.0000065898.61358.09","article-title":"Histopathological differences of myotonic dystrophy type 1 (DM1) and PROMM\/DM2","volume":"60","author":"Vihola","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.neurol.2008.02.036_bib37","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.nmd.2004.10.002","article-title":"Extraocular muscles have fundamentally distinct properties that make them selectively vulnerable to certain disorders","volume":"15","author":"Yu Wai Man","year":"2005","journal-title":"Neuromuscul Disord"}],"container-title":["Revue Neurologique"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378708001872?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0035378708001872?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,29]],"date-time":"2018-12-29T12:27:32Z","timestamp":1546086452000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0035378708001872"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,11]]},"references-count":37,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2008,11]]}},"alternative-id":["S0035378708001872"],"URL":"https:\/\/doi.org\/10.1016\/j.neurol.2008.02.036","relation":{},"ISSN":["0035-3787"],"issn-type":[{"value":"0035-3787","type":"print"}],"subject":[],"published":{"date-parts":[[2008,11]]}}}